{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:16:10Z","timestamp":1786994170037,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY005093"],"award-info":[{"award-number":["R01EY005093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.micinf.2023.105141","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T11:27:59Z","timestamp":1681903679000},"page":"105141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Controlling viral inflammatory lesions by inhibiting fatty acid metabolism"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0420-7714","authenticated-orcid":false,"given":"Engin","family":"Berber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-0334","authenticated-orcid":false,"given":"Barry T.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2023.105141_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"P\u00e5lsson-McDermott","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.micinf.2023.105141_bib2","doi-asserted-by":"crossref","first-page":"22893","DOI":"10.1074\/jbc.R113.486464","article-title":"How metabolism generates signals during innate immunity and inflammation","volume":"288","author":"McGettrick","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2023.105141_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.micinf.2023.105141_bib4","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.1700472","article-title":"Manipulating glucose metabolism during different stages of viral pathogenesis can have either detrimental or beneficial effects","volume":"199","author":"Varanasi","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105141_bib5","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.4049\/jimmunol.2100453","article-title":"Inhibiting glucose metabolism results in herpes simplex encephalitis","volume":"207","author":"Berber","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105141_bib6","doi-asserted-by":"crossref","first-page":"594963","DOI":"10.3389\/fimmu.2020.594963","article-title":"Virus infections and host metabolism\u2014can we manage the interactions?","volume":"11","author":"Sumbria","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2023.105141_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-020-0237-2","article-title":"A\u00a0metabolic handbook for the COVID-19 pandemic","volume":"2","author":"Ayres","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.micinf.2023.105141_bib8","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3389\/fmicb.2019.02314","article-title":"Factors affecting the tissue damaging consequences of viral infections","volume":"10","author":"Sumbria","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2023.105141_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","article-title":"Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells","volume":"1807","author":"Pike","year":"2011","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"10.1016\/j.micinf.2023.105141_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234493","article-title":"Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents","volume":"15","author":"M\u00f8rkholt","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2023.105141_bib11","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1042\/CS20190587","article-title":"Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR\u03b3-mediated pathway in bladder cancer","volume":"133","author":"Cheng","year":"2019","journal-title":"Clin Sci"},{"key":"10.1016\/j.micinf.2023.105141_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/v14050862","article-title":"Fraternal twins: the enigmatic role of the immune system in alphaherpesvirus pathogenesis and latency and its impacts on vaccine efficacy","volume":"14","author":"Rouse","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2023.105141_bib13","doi-asserted-by":"crossref","first-page":"e00688","DOI":"10.1128\/jvi.00688-22","article-title":"Controlling herpes simplex virus-induced immunoinflammatory lesions using metabolic therapy: a comparison of 2-Deoxy-d-Glucose with metformin","volume":"96","author":"Berber","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2023.105141_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.micinf.2018.04.007","article-title":"On the role of retinoic acid in virus induced inflammatory response in cornea","volume":"20","author":"Jaggi","year":"2018","journal-title":"Microb Infect"},{"key":"10.1016\/j.micinf.2023.105141_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/srep00079","article-title":"Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis","volume":"1","author":"Shriver","year":"2011","journal-title":"Sci Rep"},{"key":"10.1016\/j.micinf.2023.105141_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0167-5699(97)01114-6","article-title":"Immunity causing blindness: five different paths to herpes stromal keratitis","volume":"18","author":"Streilein","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.micinf.2023.105141_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.micinf.2023.105141_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02786400","article-title":"Immunopathogenesis of herpetic ocular disease","volume":"16","author":"Thomas","year":"1997","journal-title":"Immunol Res"},{"key":"10.1016\/j.micinf.2023.105141_bib19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archinte.168.10.1034","article-title":"Use of corticosteroids in treating infectious diseases","volume":"168","author":"McGee","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.micinf.2023.105141_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(02)07681-X","article-title":"Viral encephalitis: familiar infections and emerging pathogens","volume":"359","author":"Whitley","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2023.105141_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus infections in the nervous system","volume":"13","author":"Koyuncu Orkide","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micinf.2023.105141_bib22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.191.9.1459","article-title":"CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons","volume":"191","author":"Liu","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micinf.2023.105141_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-319-53168-7_3","article-title":"Innate immune mechanisms and herpes simplex virus infection and disease","volume":"223","author":"Kurt-Jones","year":"2017","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1016\/j.micinf.2023.105141_bib24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20111316","article-title":"Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood","volume":"209","author":"Herman","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micinf.2023.105141_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.0902373","article-title":"Early CD4+T cell help prevents partial CD8+ Tcell exhaustion and promotes maintenance of herpes simplex virus 1 latency","volume":"184","author":"Frank","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105141_bib26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","article-title":"Early events in HSV keratitis\u2014setting the stage for a blinding disease","volume":"7","author":"Biswas","year":"2005","journal-title":"Microb Infect"},{"key":"10.1016\/j.micinf.2023.105141_bib27","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.1100736","article-title":"Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology","volume":"187","author":"Suryawanshi","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105141_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.micinf.2023.105141_bib29","doi-asserted-by":"crossref","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457923000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457923000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:42:06Z","timestamp":1761144126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457923000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1286457923000448"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2023.105141","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlling viral inflammatory lesions by inhibiting fatty acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2023.105141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS on behalf of Institut Pasteur.","name":"copyright","label":"Copyright"}],"article-number":"105141"}}